[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100586888":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":31,"collaborators":7,"id":33,"slug":7,"hasResults":34,"nctId":35,"briefTitle":36,"officialTitle":36,"acronym":37,"eligibilityCriteria":38,"healthyVolunteers":34,"sex":39,"minAge":40,"maxAge":7,"enrollmentInfo":41,"targetDuration":7,"studyType":44,"phases":7,"briefSummary":45,"conditions":46,"keywords":49,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":61},{"fullName":5,"class":6},"Centre Hospitalier Universitaire, Amiens","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Nicolas GUILLAUME, Pr","CONTACT","33+322087046","guillaume.nicolas@chu-amiens.fr",[15],{"facility":16,"status":17,"city":18,"state":7,"zip":19,"country":20,"countryCode":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":28},"CHRU Amiens","RECRUITING","Amiens","80054","France","FR",{"type":23,"coordinates":24},"Point",[25,26],2.3,49.9,{"lat":26,"lon":25},[29],{"name":30,"role":11,"phone":12,"phoneExt":7,"email":13},"Nicolas Guillaume, Pr",{"type":32,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100586888",false,"NCT06921239","HLA Antibodies in Systemic Lupus Erythematosus","LEDHLA","Inclusion Criteria:\n\n* Patients Adults\n* Followed in the internal medicine department of Amiens University Hospital - With systemic lupus erythematosus\n* Without HLA immunization risk factors (no history of pregnancy, transfusions or transplants)\n* With sera stored in the biobank\n\nExclusion Criteria:\n\n* minor Patients\n* Opposing the re-use of their personal data for research purposes","ALL","18 Years",{"count":42,"type":43},30,"ESTIMATED","OBSERVATIONAL","Patients suffering from autoimmune diseases show false-positive results when anti-HLA antibodies are identified. This false positivity makes it difficult to obtain an organ transplant based on immunological compatibility (absence of anti-HLA antibodies directed against graft antigens). The objectives of this project are to study the prevalence of these false positivities in a population of lupus patients, and to evaluate biological tests that can negate these false positivities.",[47,48],"HLA Antibodies","Systemic Lupus Erythematosus",[50,51],"HLA antibodies","systemic lupus erythematosus","2026-01-15",{"date":54,"type":55},"2026-01-16","ACTUAL",{"date":57,"type":55},"2025-02-10",{"date":59,"type":43},"2027-05",{"name":5,"class":6},1]